Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.012
▾0.001 (9.09%)
Last trade: 26/05, 5:27AM
Market cap
$2.00m
20 min delay
Investor Presentations
Principal Activity
Hexima Limited (Hexima) is an Australia-based biotechnology company. The Company is engaged in the research and development of plant-derived defensin peptides for applications as human therapeutics. Its lead product candidate, HXP124 applied in a topical formulation, is a potential new prescription treatment for toenail fungal infections (or onychomycosis). The Company is conducting a 132 patient Australian phase IIb clinical trial of HXP124 for onychomycosis. The Company holds granted, long-life patents protecting HXP124 in markets globally.
Website
News
Announcements
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.012
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
Company | Market Cap | ||
---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia